ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ETX E-therapeutics Plc

9.60
0.425 (4.63%)
25 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
E-therapeutics Plc LSE:ETX London Ordinary Share GB00B2823H99 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.425 4.63% 9.60 9.40 9.80 9.40 9.00 9.00 2,228,014 16:35:08
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Coml Physical, Biologcl Resh 475k -8.27M -0.0142 -6.62 54.88M

e-Therapeutics plc Holding(s) in Company (0871K)

23/08/2019 11:21am

UK Regulatory


TIDMETX

RNS Number : 0871K

e-Therapeutics plc

23 August 2019

 
 
 
 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES (i) 
 
 
 
 1. Identity of the issuer or the        e-Therapeutics PLC 
  underlying issuer of existing shares 
  to which voting rights are attached: 
  (ii) 
 
 
 2 Reason for the notification (please tick the appropriate box 
  or boxes): 
 An acquisition or disposal of voting rights 
 
 An acquisition or disposal of qualifying financial instruments 
  which may result in the acquisition of shares already 
  issued to which voting rights are attached 
 
 An acquisition or disposal of instruments with similar 
  economic effect to qualifying financial instruments 
 
 An event changing the breakdown of voting rights 
 
 Other (please 
  specify): 
--------------------------------------------------------------- 
 
 
 
 3. Full name of person(s) subject         Rupert Labrum 
  to the notification obligation: (iii) 
 4. Full name of shareholder(s) 
  (if different from 3.): (iv) 
                                          -------------- 
 5. Date of the transaction and date        22/08/2019 
  on which the threshold is crossed 
  or reached: (v) 
                                          -------------- 
 6. Date on which issuer notified:          23/08/2019 
                                          -------------- 
 7. Threshold(s) that is/are crossed 
  or 
  reached: (vi, vii)                           5.00% 
                                          -------------- 
 
 
 8. Notified details: 
 A: Voting rights attached to shares (viii, ix) 
 Class/type        Situation previous     Resulting situation after the triggering 
  of                to the triggering      transaction 
  shares            transaction 
 
  if possible 
  using 
  the ISIN CODE 
                  ---------------------  -------------------------------------------------------- 
                   Number      Number     Number       Number of voting      % of voting rights 
                    of          of         of shares    rights                (x) 
                    Shares      Voting 
                                Rights 
                  ----------  ---------  -----------  --------------------  --------------------- 
                                          Direct       Direct     Indirect   Direct     Indirect 
                                                        (xi)       (xii) 
                  ----------  ---------  -----------  ---------  ---------  ---------  ---------- 
 
  GB00B2823H99     12015000    12015000   13449017     13449017              5.0% 
                  ----------  ---------  -----------  ---------  ---------  ---------  ---------- 
 
 
 B: Qualifying Financial Instruments 
 Resulting situation after the triggering transaction 
 Type of financial   Expiration     Exercise/       Number of voting         % of voting 
  instrument          date (xiii)    Conversion      rights that              rights 
                                     Period (xiv)    may be 
                                                     acquired if 
                                                     the 
                                                     instrument is 
                                                     exercised/ converted. 
                    -------------  --------------  -----------------------  ------------ 
 
 
 
 C: Financial Instruments with similar economic effect to Qualifying 
  Financial Instruments (xv, xvi) 
 Resulting situation after the triggering transaction 
 Type of financial   Exercise   Expiration     Exercise/     Number of voting     % of voting 
  instrument          price      date (xvii)    Conversion    rights instrument    rights (xix, 
                                                period        refers to            xx) 
                                                (xviii) 
                    ---------  -------------  ------------  -------------------  ---------------- 
                                                                                  Nominal   Delta 
                    ---------  -------------  ------------  -------------------  --------  ------ 
 
 
 
 Total (A+B+C) 
 Number of voting rights   Percentage of voting rights 
                          ---------------------------- 
 13449017                  5.0% 
                          ---------------------------- 
 
 
 9. Chain of controlled undertakings through which the voting 
  rights and/or the 
  financial instruments are effectively held, if applicable: (xxi) 
 
 
 
 Proxy Voting: 
 10. Name of the proxy holder: 
 
 11. Number of voting rights proxy 
  holder will cease to hold: 
 
 12. Date on which proxy holder will 
  cease to hold voting rights: 
 
 
 
 13. Additional information: 
 14. Contact name:                Rupert Labrum 
                                --------------- 
 15. Contact telephone number: 
                                --------------- 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

HOLEAEPDAFPNEFF

(END) Dow Jones Newswires

August 23, 2019 06:21 ET (10:21 GMT)

1 Year E-therapeutics Chart

1 Year E-therapeutics Chart

1 Month E-therapeutics Chart

1 Month E-therapeutics Chart

Your Recent History

Delayed Upgrade Clock